Marchex Croissance future

Future contrôle des critères 0/6

Les bénéfices de Marchex devraient diminuer de 7.6% par an tandis que son chiffre d'affaires annuel devrait croître de 4.7% par an. Le BPA devrait croître de en baisse de 5.4% par an.

Informations clés

-7.6%

Taux de croissance des bénéfices

-5.4%

Taux de croissance du BPA

Media croissance des bénéfices	13.6%
Taux de croissance des recettes	4.7%
Rendement futur des capitaux propres	n/a
Couverture par les analystes	Low
Dernière mise à jour	01 Nov 2024

Mises à jour récentes de la croissance future

Recent updates

Marchex, Inc. (NASDAQ:MCHX) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Aug 05

Will Marchex (NASDAQ:MCHX) Spend Its Cash Wisely?

Mar 01

Is Marchex (NASDAQ:MCHX) In A Good Position To Deliver On Growth Plans?

Oct 19

What You Can Learn From Marchex, Inc.'s (NASDAQ:MCHX) P/SAfter Its 26% Share Price Crash

Sep 14

Prévisions de croissance des bénéfices et des revenus

NasdaqGS:MCHX - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2026	54	-5	N/A	N/A	1
12/31/2025	50	-5	N/A	N/A	2
12/31/2024	48	-5	N/A	N/A	2
9/30/2024	49	-4	N/A	N/A	N/A
6/30/2024	49	-5	-2	-1	N/A
3/31/2024	49	-7	-3	-2	N/A
12/31/2023	50	-10	-6	-4	N/A
9/30/2023	50	-12	-8	-7	N/A
6/30/2023	50	-12	-9	-7	N/A
3/31/2023	51	-11	-7	-5	N/A
12/31/2022	52	-8	-5	-2	N/A
9/30/2022	53	-7	-5	-2	N/A
6/30/2022	53	-2	-4	-1	N/A
3/31/2022	54	-1	-5	-2	N/A
12/31/2021	53	-4	-8	-6	N/A
9/30/2021	53	-8	-8	-7	N/A
6/30/2021	53	-16	-10	-9	N/A
3/31/2021	52	-22	-8	-7	N/A
12/31/2020	51	-42	-5	-3	N/A
9/30/2020	15	-42	-5	-4	N/A
6/30/2020	26	-39	-2	0	N/A
3/31/2020	40	-34	-4	-2	N/A
12/31/2019	54	-10	3	5	N/A
9/30/2019	101	-4	6	8	N/A
6/30/2019	96	-4	7	8	N/A
3/31/2019	90	-3	6	8	N/A
12/31/2018	85	-3	3	5	N/A
9/30/2018	84	-3	2	4	N/A
6/30/2018	86	-3	N/A	4	N/A
3/31/2018	88	-4	N/A	6	N/A
12/31/2017	90	-6	N/A	2	N/A
9/30/2017	97	-11	N/A	1	N/A
6/30/2017	106	-16	N/A	-2	N/A
3/31/2017	118	-84	N/A	-2	N/A
12/31/2016	130	-84	N/A	-4	N/A
9/30/2016	136	-77	N/A	-2	N/A
6/30/2016	142	-71	N/A	6	N/A
3/31/2016	143	-4	N/A	4	N/A
12/31/2015	143	-1	N/A	13	N/A
9/30/2015	139	-2	N/A	16	N/A
6/30/2015	150	-24	N/A	15	N/A
3/31/2015	161	-23	N/A	21	N/A
12/31/2014	174	-23	N/A	22	N/A
9/30/2014	182	-22	N/A	24	N/A
6/30/2014	175	1	N/A	22	N/A
3/31/2014	166	1	N/A	20	N/A
12/31/2013	148	-2	N/A	14	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: MCHX devrait rester non rentable au cours des 3 prochaines années.

Bénéfices vs marché: MCHX devrait rester non rentable au cours des 3 prochaines années.

Croissance élevée des bénéfices: MCHX devrait rester non rentable au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de MCHX ( 4.7% par an) devrait croître plus lentement que le marché de US ( 8.9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de MCHX ( 4.7% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de MCHX devrait être élevé dans 3 ans

Marchex Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2024 and First Quarter and Full Year of 2025

Consensus EPS estimates upgraded to US$0.085 loss

Marchex, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2024

Marchex, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2024

Consensus EPS estimates upgraded to US$0.12 loss, revenue downgraded

Marchex, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year of 2024

Recent updates

New major risk - Revenue and earnings growth

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2024 and First Quarter and Full Year of 2025

Third quarter 2024 earnings: EPS misses analyst expectations

Marchex Announces Additional AI Solutions to Empower Businesses

Marchex, Inc. to Report Q3, 2024 Results on Oct 31, 2024

Marchex, Inc., Annual General Meeting, Oct 30, 2024

Marchex, Inc., Annual General Meeting, Oct 30, 2024

Consensus EPS estimates upgraded to US$0.085 loss

Second quarter 2024 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2024

Marchex, Inc. (NASDAQ:MCHX) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Marchex, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Chief Executive Officer recently bought US$272k worth of stock

New minor risk - Shareholder dilution

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Marchex, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2024

Marchex, Inc. to Report Q1, 2024 Results on May 07, 2024

Marchex Launches Generative Ai-Powered Sentiment Suite Across Multiple Apis

Consensus EPS estimates upgraded to US$0.12 loss, revenue downgraded

Full year 2023 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year of 2024

Marchex, Inc. to Report Q4, 2023 Results on Mar 14, 2024

Will Marchex (NASDAQ:MCHX) Spend Its Cash Wisely?

Third quarter 2023 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for Fourth Quarter Ending December 31, 2023 and Fiscal Year 2024

New major risk - Revenue and earnings growth

Marchex, Inc. Launches Call Summary and Sentiment Suite Capabilities for Vertical Markets

Marchex, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Is Marchex (NASDAQ:MCHX) In A Good Position To Deliver On Growth Plans?

What You Can Learn From Marchex, Inc.'s (NASDAQ:MCHX) P/SAfter Its 26% Share Price Crash

Marchex, Inc., Annual General Meeting, Sep 28, 2023

New major risk - Financial position

Second quarter 2023 earnings: EPS exceeds analyst expectations

Companies Like Marchex (NASDAQ:MCHX) Are In A Position To Invest In Growth

Consensus EPS estimates fall by 29%

First quarter 2023 earnings: EPS misses analyst expectations

Full year 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 66%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.1% to US$3.25

Marchex, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Marchex, Inc. Announces Executive Changes

We're Not Very Worried About Marchex's (NASDAQ:MCHX) Cash Burn Rate

Insufficient new directors

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Marchex, Inc. to Report Q3, 2022 Results on Nov 03, 2022

We're Hopeful That Marchex (NASDAQ:MCHX) Will Use Its Cash Wisely

Marchex, Inc., Annual General Meeting, Sep 29, 2022

Consensus forecasts updated

Second quarter 2022 earnings: EPS exceeds analyst expectations

Marchex, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Insufficient new directors

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Second Quarter of 2022

Marchex, Inc. to Report Q1, 2022 Results on May 12, 2022

Insufficient new directors

Price target decreased to US$3.50

We're Hopeful That Marchex (NASDAQ:MCHX) Will Use Its Cash Wisely

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Marchex Inc. Launches Conversation Dna, Delivering Powerful Ai Signals Through Every Marchex Conversation Intelligence Product

Marchex, Inc. to Report Q4, 2021 Results on Mar 02, 2022

Price target decreased to US$4.00

Third quarter 2021 earnings released: EPS US$0.083 (vs US$0.078 loss in 3Q 2020)

Marchex: Hope Springs Eternal

Second quarter 2021 earnings released: US$0.008 loss per share (vs US$0.096 loss in 2Q 2020)

Does Marchex (NASDAQ:MCHX) Have A Healthy Balance Sheet?

Consensus EPS estimates increase to -US$0.29